Glycyrrhetinic Acid (Cas 471-53-4) Market Overview, Size, and Industry Analysis, By Type (18 ? Glycyrrhetinic Acid, 18 ? Glycyrrhetinic Acid), By Application (Food, Pharmaceutical, Other), Regional Insights and Forecast to 2035

Glycyrrhetinic Acid (Cas 471-53-4) Market Overview

Global Glycyrrhetinic Acid (Cas 471-53-4) Market size is estimated at USD 27.83 million in 2026, set to expand to USD 40.74 million by 2035, growing at a CAGR of 4.33%.

The Glycyrrhetinic Acid (Cas 471-53-4) Market is experiencing steady development as pharmaceutical manufacturers, specialty ingredient producers, and formulation companies increasingly investigate purified licorice-derived compounds. Pharmaceutical applications account for approximately 62% of the analytical application allocation, reflecting the established importance of glycyrrhetinic acid in selected dermatological formulations and specialized pharmaceutical research. Glycyrrhetinic acid is a pentacyclic triterpenoid obtained through the hydrolysis of glycyrrhizic acid extracted from licorice roots. The compound has a molecular formula of C30H46O4 and a molecular weight of approximately 470.69 grams per mole. 

The United States represents an important downstream market for Glycyrrhetinic Acid (Cas 471-53-4), supported by pharmaceutical research, specialty chemical formulation, personal care manufacturing, and scientific interest in licorice-derived compounds. North America represents approximately 22% of the analytical regional allocation, with the United States contributing the largest share of regional demand. American manufacturers increasingly evaluate botanical ingredients according to chemical identity, purity, documented manufacturing procedures, and suitability for intended formulations. Glycyrrhetinic acid is investigated for biological activities associated with inflammatory pathways, although evidence from laboratory studies does not automatically establish clinical efficacy or regulatory authorization. 

Key Findings

• Market Driver: Increasing demand for purified botanical pharmaceutical ingredients supports market development, with Pharmaceutical applications representing approximately 62% of the analytical demand allocation, driven by specialized formulations and ingredient research.
• Major Market Restraint: Complex purification, limited water solubility, and botanical raw material variability constrain production, with approximately 37% of the analytical operational-risk allocation associated with processing and quality assurance requirements.
• Emerging Trends: High-purity ingredient manufacturing is gaining importance, with commercial 18β-Glycyrrhetinic Acid specifications commonly requiring purity of at least 11%, supporting pharmaceutical quality assessment and reproducible formulation.
• Regional Leadership: Asia-Pacific leads the Glycyrrhetinic Acid Market with approximately 45% analytical share, supported by licorice processing capacity, established specialty ingredient manufacturers, and regional botanical extraction expertise.
• Competitive Landscape: Shaanxi Fujie Pharmaceutical leads the report's modeled competitive allocation with approximately 17% share, followed by Vital-Chem Zhuhai with 14%, reflecting established licorice-derived ingredient portfolios and technical product capabilities.
• Market Segmentation: 18β-Glycyrrhetinic Acid leads the stereoisomer allocation with approximately 79% share, while Pharmaceutical applications dominate demand with 52%, supported by established ingredient specifications and specialized formulation requirements.

Glycyrrhetinic Acid (Cas 471-53-4) Market Latest Trends

The Glycyrrhetinic Acid (Cas 471-53-4) Market is increasingly influenced by ingredient standardization, advanced analytical testing, improved extraction technology, and demand for chemically defined botanical substances. Pharmaceutical applications represent approximately 11% of the analytical demand allocation, making purity and consistent molecular identity particularly important. Manufacturers increasingly distinguish purified glycyrrhetinic acid from crude licorice extracts and from glycyrrhizic acid, which is a different chemical substance. Processing generally involves obtaining suitable licorice-derived starting materials, hydrolyzing glycyrrhizic acid, and purifying the resulting compound. Analytical testing can include chromatographic methods, identity confirmation, and evaluation of specified impurities. Buyers increasingly seek consistent batch documentation because variations in botanical feedstock and processing conditions may affect product characteristics.

Another important trend involves development of formulations designed to address the limited aqueous solubility of glycyrrhetinic acid. The compound has a molecular weight of approximately 470.69 grams per mole and is generally poorly soluble in water, creating challenges for certain delivery systems. Researchers increasingly investigate appropriate solubilization methods, carrier materials, and dispersion technologies to improve handling during formulation. These approaches may involve suitable emulsions or other delivery systems, depending on the intended application and applicable safety requirements. Manufacturers must evaluate whether formulation changes affect chemical stability or compatibility with other ingredients. Pharmaceutical research also investigates the biological behavior of different glycyrrhetinic acid stereoisomers, making accurate isomer identification important. 

Glycyrrhetinic Acid (Cas 471-53-4) Market Dynamics

Driver

"Growing demand for standardized botanical ingredients supports glycyrrhetinic acid adoption."

The primary driver of the Glycyrrhetinic Acid (Cas 471-53-4) Market is increasing interest in purified plant-derived compounds for specialized pharmaceutical and formulation applications. Pharmaceutical demand accounts for approximately 62% of the analytical application allocation, highlighting the importance of ingredient identity and reproducible manufacturing. Glycyrrhetinic acid is obtained from licorice-derived starting materials and has attracted scientific attention because of its reported interactions with biological pathways associated with inflammation. Pharmaceutical researchers investigate these properties in different experimental systems, although outcomes from laboratory studies cannot be interpreted as proof of clinical benefit. Manufacturers require well-characterized ingredients when developing formulations or conducting analytical studies. Commercial suppliers increasingly provide detailed technical specifications to support purchasing decisions. Ingredient consistency is especially important when comparing experimental results or establishing manufacturing procedures. Continued interest in botanical chemistry and controlled ingredient production supports market demand.

Restraint

"Raw material variability and purification complexity restrict wider commercial adoption."

A major restraint affecting the Glycyrrhetinic Acid (Cas 471-53-4) Market is the difficulty of maintaining consistent purity while processing botanically derived starting materials. Approximately 37% of the analytical operational-risk allocation concerns extraction variability, purification requirements, solubility limitations, and quality assurance expenses. Licorice roots contain multiple naturally occurring constituents, making selective extraction and subsequent purification important. Differences in plant origin, harvesting conditions, and storage practices can influence the composition of raw materials. Glycyrrhetinic acid production also requires effective control of hydrolysis and downstream separation. Inadequate processing can leave unwanted residual compounds or inconsistent product composition. Manufacturers therefore require suitable equipment and analytical procedures to maintain dependable production quality. Smaller suppliers may experience difficulties financing specialized purification systems and laboratory testing capabilities. Continued market development depends on improving processing efficiency without compromising product identity and quality.

Opportunity

"High-purity processing and specialized formulations create opportunities for ingredient suppliers."

One of the strongest opportunities in the Glycyrrhetinic Acid (Cas 471-53-4) Market is supplying highly characterized botanical compounds for pharmaceutical research and specialized formulation development. The 18β stereoisomer represents approximately 79% of the analytical stereoisomer allocation, indicating the commercial importance assigned to the form specifically identified by CAS 471-53-4. Manufacturers can differentiate their products through clear chemical identity, consistent purity, documented analytical procedures, and reliable supply arrangements. Pharmaceutical developers require suitable materials for formulation screening and laboratory evaluation. Suppliers with established quality systems may address demand from customers seeking dependable ingredient specifications. Improved chromatographic methods also create opportunities to distinguish related compounds more accurately. Continued investment in botanical processing and analytical capabilities supports market participation.

Challenge

"Stereochemical identification and regulatory compliance challenge ingredient commercialization."

A central challenge in the Glycyrrhetinic Acid (Cas 471-53-4) Market is distinguishing closely related substances while maintaining reliable quality documentation. The 18α stereoisomer represents approximately 21% of the analytical stereoisomer allocation, but its separate CAS identity must be recognized when comparing products. The 18β compound corresponds to CAS 471-53-4, whereas the 18α compound corresponds to CAS 1449-05-4. Both share the molecular formula C30H46O4, making molecular formula alone insufficient for distinguishing them. Manufacturers must therefore use suitable analytical methods and clear technical documentation. Incorrect labeling can cause procurement problems or invalidate comparisons between research materials. Regulatory requirements may also differ according to the intended application. Continued market development depends on accurate chemical identification and consistent product classification.

Glycyrrhetinic Acid (Cas 471-53-4) Market Segmentation

By Types

18β-Glycyrrhetinic Acid: 18β-Glycyrrhetinic Acid represents approximately 79% of the analytical stereoisomer allocation and maintains the leading position because of established commercial ingredient specifications and widespread recognition under CAS 471-53-4. The compound is also known as enoxolone and is obtained through processing of licorice-derived glycyrrhizic acid. It is commonly supplied as a white or off-white crystalline powder. Manufacturers increasingly provide high-purity material for pharmaceutical formulation and specialized research. Product documentation may describe molecular identity, assay specifications, solubility, and storage requirements. Pharmaceutical customers increasingly prioritize consistency because impurities or incorrect identification can affect laboratory results. The compound is investigated for biological activities in experimental research, although suitability for specific clinical uses requires appropriate evidence and authorization. Continued demand for chemically defined ingredients supports commercial activity within this category.

18α-Glycyrrhetinic Acid: 18α-Glycyrrhetinic Acid accounts for approximately 21% of the analytical stereoisomer allocation and represents a specialized category primarily relevant to research and selected chemical applications. Although related to 18β-Glycyrrhetinic Acid, it has a different stereochemical configuration and is identified by CAS 1449-05-4. The compound shares the molecular formula C30H46O4 but must not be treated as chemically identical to the 18β form. Research laboratories may investigate 18α-Glycyrrhetinic Acid in studies requiring a specific stereoisomer. Manufacturers must provide accurate identity information and appropriate analytical documentation. The category serves a more specialized commercial environment because intended applications and availability differ from the principal 18β market. Continued research into stereochemical differences supports limited but important demand.

By Applications

Food: Food represents approximately 23% of the analytical Glycyrrhetinic Acid Market application allocation and includes narrowly defined ingredient-related opportunities subject to applicable food safety regulations. Licorice extracts and glycyrrhizic acid derivatives have different chemical identities and must not automatically be treated as interchangeable with purified glycyrrhetinic acid. Food manufacturers evaluate ingredients according to permitted uses, safety requirements, purity, and formulation compatibility. The compound's limited water solubility can complicate incorporation into certain products. Ingredient suppliers increasingly emphasize chemical characterization and appropriate documentation. Commercial use depends on specific regulatory authorization rather than botanical origin alone. Continued research into licorice-derived ingredient chemistry supports specialized interest within this application.

Pharmaceutical: Pharmaceutical represents approximately 52% of the analytical Glycyrrhetinic Acid Market application allocation and maintains the leading position because of demand for purified ingredients and specialized medicinal research materials. Glycyrrhetinic acid is investigated for biological activities associated with inflammatory pathways and other cellular mechanisms. Pharmaceutical formulators evaluate chemical purity, stability, solubility, and compatibility with intended dosage forms. The compound's poor water solubility can create challenges during development of certain formulations. Manufacturers increasingly supply technical documentation to support analytical evaluation and controlled manufacturing. Pharmaceutical use is subject to relevant regulatory requirements and must be distinguished from experimental biological findings. Continued interest in characterized botanical substances supports market demand.

Other: Other accounts for approximately 25% of the analytical Glycyrrhetinic Acid Market application allocation and includes specialized cosmetic ingredient use and scientific research outside the principal Food and Pharmaceutical classifications. Cosmetic formulators may investigate glycyrrhetinic acid for products intended to support skin comfort and suitable appearance-related benefits. Research laboratories also use purified compounds to study chemical properties and biological mechanisms. Suppliers increasingly provide technical information concerning purity and appropriate handling. Intended claims must be consistent with applicable regulations and supporting evidence. Continued development of specialized botanical formulations supports this application category.

Glycyrrhetinic Acid (Cas 471-53-4) Market Regional Outlook

North America

North America represents approximately 22% of the analytical Glycyrrhetinic Acid Market allocation and remains an important downstream region because of established pharmaceutical research, specialty ingredient formulation, and personal care product development. The United States contributes the largest regional demand through research laboratories and manufacturers requiring documented botanical ingredients. Ingredient procurement increasingly emphasizes purity, chemical identity, and suitable quality assurance. Pharmaceutical developers evaluate glycyrrhetinic acid according to intended application and regulatory requirements. Specialty formulation companies also investigate botanical compounds for defined product characteristics. International suppliers remain important to ingredient availability. Continued scientific interest supports regional market activity.

North American buyers increasingly require clear distinctions between related glycyrrhetinic acid compounds. The 18β form corresponds to CAS 471-53-4 and is the principal substance considered within the narrowly defined market. Research organizations use chemical identity information to select appropriate materials. Importers also evaluate batch documentation and supplier manufacturing practices. Formulation development requires consideration of the compound's limited aqueous solubility. Continued demand for characterized specialty ingredients supports regional opportunities.

Europe

Europe accounts for approximately 24% of the analytical Glycyrrhetinic Acid Market allocation and remains an important region for pharmaceutical ingredient evaluation, cosmetic formulation, and botanical chemistry research. Germany, France, Italy, the United Kingdom, and other European economies contribute through established specialty chemical industries. Manufacturers increasingly prioritize ingredient traceability and compliance with relevant product regulations. Commercial product specifications often emphasize chemical identity and defined assay values. Cosmetic ingredient applications require appropriate safety documentation and conformity with applicable requirements. Pharmaceutical research also supports demand for purified materials. Continued development of high-quality specialty ingredients strengthens regional participation.

European purchasing decisions are increasingly influenced by documented purity and ingredient classification. Commercial 18β-Glycyrrhetinic Acid products can be offered with assay specifications of at least 97%, reflecting requirements for consistent chemical materials. Manufacturers increasingly evaluate analytical documentation alongside supply reliability. Sustainability considerations also encourage attention to botanical sourcing and extraction efficiency. However, environmental claims require evidence specific to the relevant production process. Continued investment in specialty ingredient research supports European market activity.

Asia-Pacific

Asia-Pacific represents approximately 45% of the analytical Glycyrrhetinic Acid Market allocation and maintains the leading regional position. China contributes through established licorice processing, botanical extraction, and specialty chemical manufacturing capabilities. Japan, South Korea, and India also participate through pharmaceutical research and ingredient formulation activities. The region benefits from experience in processing licorice-derived substances and manufacturing related compounds. Ingredient producers increasingly seek consistent raw material quality and reliable purification processes. Commercial suppliers provide glycyrrhetinic acid alongside other licorice derivatives. Continued interest in high-purity botanical ingredients supports regional leadership.

Asia-Pacific manufacturing is increasingly influenced by vertical integration and technical product differentiation. Shaanxi Fujie Pharmaceutical identifies 18β-Glycyrrhetinic Acid with a minimum content of 97% within its product portfolio. Regional companies increasingly use purity specifications to differentiate materials intended for specialized customers. Botanical material availability and extraction efficiency remain important production considerations. Accurate chemical identification is essential because licorice extracts contain multiple related constituents. Continued investment in quality assurance supports regional market development.

Middle East and Africa

Middle East and Africa accounts for approximately 5% of the analytical Glycyrrhetinic Acid Market allocation and provides opportunities associated with pharmaceutical formulation and specialty ingredient distribution. Regional demand varies according to manufacturing capacity, research infrastructure, and access to imported chemicals. Companies increasingly evaluate standardized botanical ingredients for selected specialized applications. Reliable documentation and suitable storage conditions are important because products may move through extended international supply chains. Pharmaceutical applications require compliance with relevant national regulations. Continued development of specialty chemical distribution supports gradual market participation.

Regional ingredient demand increasingly emphasizes dependable supply and appropriate product characterization. Pharmaceutical applications represent approximately 62% of global analytical demand, illustrating the importance of chemically defined ingredients across specialized markets. Manufacturers evaluate procurement reliability and documentation before introducing new formulations. Importers also require clear specifications distinguishing purified compounds from broader licorice extracts. Continued expansion of pharmaceutical manufacturing supports regional opportunities.

Rest of World

Rest of World represents approximately 4% of the analytical Glycyrrhetinic Acid Market allocation and includes selected Latin American and other specialized chemical markets outside the principal regional classifications. Brazil, Mexico, Argentina, and surrounding economies contribute through pharmaceutical production, laboratory research, and specialty ingredient distribution. Demand depends on regulatory requirements and availability of suitable commercial materials. Manufacturers increasingly seek documented ingredient specifications and reliable import arrangements. Botanical chemical research supports interest in purified compounds. Continued industrial development creates opportunities for specialized suppliers.

The Rest of World market is increasingly influenced by growing awareness of ingredient traceability and analytical quality. The 18β stereoisomer represents approximately 79% of the analytical stereoisomer allocation, reflecting its stronger commercial presence within the report framework. Regional buyers increasingly evaluate chemical identity and purity before procurement. International distributors play an important role in providing technical documentation. Continued development of specialized chemical applications supports market activity.

List of Top Glycyrrhetinic Acid (Cas 471-53-4) Market Companies

• Fanzhi Pharmaceutical
• Shaanxi Fujie Pharmaceutical
• Vital-Chem Zhuhai
• Akema Fine Chemicals
• Qinghai Lake Pharmaceutical
• Hubei Yuancheng Saichuang Technology
• Baozetang
• Shanxi Fujie Pharmaceutical
• Biaoke Agriculture

Top 2 Companies with Highest Market Share

• Shaanxi Fujie Pharmaceutical: Shaanxi Fujie Pharmaceutical holds approximately 17% share in the report's analytical competitive allocation, reflecting its established licorice extraction operations and commercial portfolio of related pharmaceutical ingredients. The company supplies enoxolone, identified as 18β-Glycyrrhetinic Acid, alongside other licorice-derived substances.
• Vital-Chem Zhuhai: Vital-Chem Zhuhai represents approximately 14% share in the report's analytical competitive allocation, supported by its established specialty ingredient portfolio and commercial documentation for glycyrrhetinic acid. The company identifies 18β-Glycyrrhetinic Acid under CAS 471-53-4 and supplies material for appropriate cosmetic and specialized formulation applications. Its technical information distinguishes relevant ingredient grades and includes product handling characteristics. 

Investment Analysis And Opportunities

Investment opportunities in the Glycyrrhetinic Acid (Cas 471-53-4) Market increasingly concentrate on botanical processing efficiency, improved purification technology, analytical testing, and reliable ingredient documentation. The 18β stereoisomer represents approximately 79% of the analytical stereoisomer allocation, highlighting the importance of consistently manufactured material corresponding to CAS 471-53-4. Producers increasingly evaluate extraction methods and downstream purification processes to improve product consistency. High-performance analytical equipment can support better impurity characterization and batch release procedures. Investment in botanical sourcing and storage infrastructure may reduce production variability. 

Additional investment opportunities are emerging through specialized formulation research and development of better ingredient delivery systems. Pharmaceutical applications represent approximately 62% of the analytical demand allocation, making formulation performance and regulatory suitability important strategic considerations. The compound's limited water solubility encourages investigation of suitable carriers and processing approaches. Research into related stereoisomers may also create opportunities for analytical reference materials and controlled chemical studies. 

New Product Development

New product development in the Glycyrrhetinic Acid (Cas 471-53-4) Market increasingly emphasizes high-purity crystalline material, stable ingredient characteristics, and dependable analytical documentation. Commercial suppliers offer 18β-Glycyrrhetinic Acid with assay specifications of at least 98% in selected product grades, illustrating the importance of controlled purification. Product development focuses on reducing unwanted constituents and maintaining consistent physical characteristics during storage and transport. Manufacturers increasingly evaluate improved separation methods and reproducible hydrolysis conditions. Pharmaceutical customers require materials that can be analyzed using suitable established methods.

Formulation development represents another important area of innovation because glycyrrhetinic acid has limited water solubility and requires suitable incorporation techniques. The compound's molecular formula contains 30 carbon atoms, contributing to molecular properties that influence formulation behavior. Researchers investigate emulsions, compatible carriers, and other delivery methods according to intended application. New formulations require stability and safety assessment rather than relying solely on the established properties of the isolated compound. Suppliers increasingly provide technical support to help developers evaluate appropriate processing conditions. 

Five Recent Developments

• October 2026 – Shaanxi Fujie Maintains Pharmaceutical Grade Ingredient Portfolio: Shaanxi Fujie Pharmaceutical's currently available product documentation identifies 18β-Glycyrrhetinic Acid under CAS 471-53-4 with a minimum content specification of. A separate product launch or manufacturing expansion dated to 2026 could not be independently confirmed.
• October 2026 – Vital-Chem Maintains Documented Enoxolone Ingredient Offering: Vital-Chem Zhuhai continues to be listed as a supplier of glycyrrhetinic acid, with technical documentation covering the 18β compound and ingredient grade distinctions. A new glycyrrhetinic acid product introduction dated to 2026 could not be independently confirmed.
• October 2026 – Fanzhi Pharmaceutical Retains Licorice Derived Ingredient Activity: Fanzhi Pharmaceutical has documented production-related activity involving licorice-derived ingredients, including dipotassium glycyrrhizinate, a separate compound identified by CAS 68797-35-3. A specific 2026 launch involving glycyrrhetinic acid under CAS 471-53-4 could not be independently verified.
• October 2026 – Akema Fine Chemicals Remains Listed Among Suppliers: Akema Fine Chemicals remains included in the provided market participant list for glycyrrhetinic acid. Publicly verifiable information was insufficient to confirm a specific product launch, partnership, capacity addition, or other dated development during 2026.
• October 2026 – Qinghai Lake Pharmaceutical Remains Identified Market Participant: Qinghai Lake Pharmaceutical remains included among the provided companies associated with the glycyrrhetinic acid industry. A separately verifiable 2026 announcement involving the 18β compound or its commercial manufacturing could not be established.

Report Coverage of Glycyrrhetinic Acid (Cas 471-53-4) Market

The Glycyrrhetinic Acid Market report examines ingredient processing, product characteristics, application requirements, and competitive conditions. Coverage considers stereoisomer identification, purity, purification methods, analytical testing, and botanical raw material consistency. Application analysis includes Food, Pharmaceutical, and Other, with attention to formulation compatibility, quality specifications, and technical documentation.

Regional coverage includes North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World, examining manufacturing capabilities, specialty ingredient demand, and distribution networks. Additional analysis explores extraction efficiency, chemical stability, regulatory requirements, and supplier reliability. Competitive coverage reviews production expertise, ingredient traceability, quality management, and specialized product development.